Individuals 0 11 0 11 O
considered 12 22 12 22 O
an 23 25 23 25 O
immediate 26 35 26 35 O
suicide 36 43 36 43 B-chronic_disease
risk 44 48 44 48 O
or 49 51 49 51 O
who 52 55 52 55 O
are 56 59 56 59 O
likely 60 66 60 66 O
to 67 69 67 69 O
require 70 77 70 77 O
hospitalization 78 93 78 93 O
during 94 100 94 100 O
the 101 104 101 104 O
course 105 111 105 111 O
of 112 114 112 114 O
the 115 118 115 118 O
study 119 124 119 124 O

Individuals 0 11 125 136 O
currently 12 21 137 146 O
taking 22 28 147 153 O
alpha 29 34 154 159 B-treatment
blockers 35 43 160 168 I-treatment
( 44 45 169 170 O
terazosin 45 54 170 179 B-treatment
, 54 55 179 180 O
prazosin 56 64 181 189 B-treatment
) 64 65 189 190 O
, 65 66 190 191 O
hypnotics 67 76 192 201 B-treatment
/ 76 77 201 202 I-treatment
benzodiazepines 77 92 202 217 I-treatment
, 92 93 217 218 O
atypical 94 102 219 227 B-treatment
antipsychotics 103 117 228 242 I-treatment
( 118 119 243 244 O
olanzapine 119 129 244 254 B-treatment
, 129 130 254 255 O
quetiapine 131 141 256 266 B-treatment
, 141 142 266 267 O
risperidone 143 154 268 279 B-treatment
, 154 155 279 280 O
clozapine 156 165 281 290 B-treatment
) 165 166 290 291 O
, 166 167 291 292 O
alpha-2 168 175 293 300 B-treatment
- 175 176 300 301 I-treatment
agonists 176 184 301 309 I-treatment
( 185 186 310 311 O
Clonidine 186 195 311 320 B-treatment
, 195 196 320 321 O
methyldopa 197 207 322 332 B-treatment
, 207 208 332 333 O
tizanidine 209 219 334 344 B-treatment
, 219 220 344 345 O
guanfacine 221 231 346 356 B-treatment
) 231 232 356 357 O
, 232 233 357 358 O
conivaptan 234 244 359 369 B-treatment
, 244 245 369 370 O
boceprevir 246 256 371 381 B-treatment
, 256 257 381 382 O
idelalisib 258 268 383 393 B-treatment
, 268 269 393 394 O
PDE-5 270 275 395 400 B-treatment
inhibitors 276 286 401 411 I-treatment
or 287 289 412 414 O
alpha-1 290 297 415 422 B-treatment
- 297 298 422 423 I-treatment
antagonists 298 309 423 434 I-treatment
, 309 310 434 435 O
protease 311 319 436 444 B-treatment
inhibitors 320 330 445 455 I-treatment
( 331 332 456 457 O
treatment 332 341 457 466 B-treatment
of 342 344 467 469 O
HIV 345 348 470 473 B-chronic_disease
) 348 349 473 474 O
, 349 350 474 475 O
oral 351 355 476 480 B-treatment
antifungals 356 367 481 492 I-treatment
, 367 368 492 493 O
alfuzosin 369 378 494 503 B-treatment
, 378 379 503 504 O
pazopanib 380 389 505 514 B-treatment
, 389 390 514 515 O
silodosin 391 400 516 525 B-treatment
, 400 401 525 526 O
tadalafil 402 411 527 536 B-treatment
, 411 412 536 537 O
or 413 415 538 540 O
tamulosin 416 425 541 550 B-treatment

Individuals 0 11 551 562 O
with 12 16 563 567 O
a 17 18 568 569 O
history 19 26 570 577 O
of 27 29 578 580 O
or 30 32 581 583 O
current 33 40 584 591 O
medical 41 48 592 599 O
illness 49 56 600 607 O
including 57 66 608 617 O
unstable 67 75 618 626 B-chronic_disease
angina 76 82 627 633 I-chronic_disease
, 82 83 633 634 O
myocardial 84 94 635 645 B-chronic_disease
infarction 95 105 646 656 I-chronic_disease
, 105 106 656 657 O
congestive 107 117 658 668 B-chronic_disease
heart 118 123 669 674 I-chronic_disease
failure 124 131 675 682 I-chronic_disease
or 132 134 683 685 O
other 135 140 686 691 O
cardiac 141 148 692 699 B-chronic_disease
condition 149 158 700 709 I-chronic_disease
, 158 159 709 710 O
hypotension 160 171 711 722 B-chronic_disease
, 171 172 722 723 O
renal 173 178 724 729 B-chronic_disease
or 179 181 730 732 O
hepatic 182 189 733 740 B-chronic_disease
disorders 190 199 741 750 I-chronic_disease
, 199 200 750 751 O
endocrine 201 210 752 761 B-chronic_disease
disorders 211 220 762 771 I-chronic_disease
, 220 221 771 772 O
prostate 222 230 773 781 B-cancer
or 231 233 782 784 O
other 234 239 785 790 O
cancer 240 246 791 797 B-cancer
, 246 247 797 798 O
pancreatitis 248 260 799 811 B-chronic_disease
, 260 261 811 812 O
or 262 264 813 815 O
a 265 266 816 817 O
seizure 267 274 818 825 B-chronic_disease
disorder 275 283 826 834 I-chronic_disease

MRI 0 3 835 838 O
exclusions 4 14 839 849 O
: 14 15 849 850 O
Claustrophobia 16 30 851 865 B-chronic_disease
; 30 31 865 866 O
tattoos 32 39 867 874 O
above 40 45 875 880 O
the 46 49 881 884 O
shoulders 50 59 885 894 O
after 60 65 895 900 O
evaluation 66 76 901 911 O
by 77 79 912 914 O
MRI 80 83 915 918 O
technician 84 94 919 929 O
; 94 95 929 930 O
permanent 96 105 931 940 O
eyeliner 106 114 941 949 B-treatment
or 115 117 950 952 O
permanent 118 127 953 962 O
artificial 128 138 963 973 O
eyebrows 139 147 974 982 O
; 147 148 982 983 O
cardiac 149 156 984 991 B-treatment
pacemaker 157 166 992 1001 I-treatment
; 166 167 1001 1002 O
metal 168 173 1003 1008 B-treatment
fragments 174 183 1009 1018 I-treatment
in 184 186 1019 1021 O
eye 187 190 1022 1025 O
, 190 191 1025 1026 O
skin 192 196 1027 1031 O
, 196 197 1031 1032 O
or 198 200 1033 1035 O
body 201 205 1036 1040 O
, 205 206 1040 1041 O
including 207 216 1042 1051 O
shrapnel 217 225 1052 1060 B-treatment
; 225 226 1060 1061 O
heart 227 232 1062 1067 B-treatment
valve 233 238 1068 1073 I-treatment
replacement 239 250 1074 1085 I-treatment
; 250 251 1085 1086 O
brain 252 257 1087 1092 B-treatment
clips 258 263 1093 1098 I-treatment
; 263 264 1098 1099 O
venous 265 271 1100 1106 B-treatment
umbrella 272 280 1107 1115 I-treatment
; 280 281 1115 1116 O
being 282 287 1117 1122 O
a 288 289 1123 1124 O
sheet 290 295 1125 1130 O
- 295 296 1130 1131 O
metal 296 301 1131 1136 O
worker 302 308 1137 1143 O
or 309 311 1144 1146 O
welder 312 318 1147 1153 O
; 318 319 1153 1154 O
lifetime 320 328 1155 1163 O
history 329 336 1164 1171 O
of 337 339 1172 1174 O
aneurysm 340 348 1175 1183 B-treatment
surgery 349 356 1184 1191 I-treatment
; 356 357 1191 1192 O
intracranial 358 370 1193 1205 B-treatment
bypass 371 377 1206 1212 I-treatment
, 377 378 1212 1213 O
renal 379 384 1214 1219 B-treatment
, 384 385 1219 1220 O
or 386 388 1221 1223 O
aortic 389 395 1224 1230 B-treatment
clips 396 401 1231 1236 I-treatment
; 401 402 1236 1237 O
prosthetic 403 413 1238 1248 B-treatment
devices 414 421 1249 1256 I-treatment
such 422 426 1257 1261 O
as 427 429 1262 1264 O
middle 430 436 1265 1271 B-treatment
ear 437 440 1272 1275 I-treatment
, 440 441 1275 1276 O
eye 442 445 1277 1280 O
, 445 446 1280 1281 O
joint 447 452 1282 1287 B-treatment
, 452 453 1287 1288 O
or 454 456 1289 1291 O
penile 457 463 1292 1298 B-treatment
implants 464 472 1299 1307 I-treatment
; 472 473 1307 1308 O
joint 474 479 1309 1314 B-treatment
replacements 480 492 1315 1327 I-treatment
; 492 493 1327 1328 O
non 494 497 1329 1332 B-treatment
- 497 498 1332 1333 I-treatment
removable 498 507 1333 1342 I-treatment
hearing 508 515 1343 1350 I-treatment
aid 516 519 1351 1354 I-treatment
, 519 520 1354 1355 O
neurostimulator 521 536 1356 1371 B-treatment
, 536 537 1371 1372 O
or 538 540 1373 1375 O
insulin 541 548 1376 1383 B-treatment
pump 549 553 1384 1388 I-treatment
; 553 554 1388 1389 O
shunts 555 561 1390 1396 B-treatment
/ 561 562 1396 1397 I-treatment
stents 562 568 1397 1403 I-treatment
; 568 569 1403 1404 O
metal 570 575 1405 1410 B-treatment
mesh 576 580 1411 1415 I-treatment
/ 580 581 1415 1416 I-treatment
coil 581 585 1416 1420 I-treatment
implants 586 594 1421 1429 I-treatment
; 594 595 1429 1430 O
metal 596 601 1431 1436 B-treatment
plate 602 607 1437 1442 I-treatment
/ 607 608 1442 1443 O
pin 608 611 1443 1446 B-treatment
/ 611 612 1446 1447 O
screws 612 618 1447 1453 B-treatment
/ 618 619 1453 1454 O
wires 619 624 1454 1459 B-treatment
; 624 625 1459 1460 O
or 626 628 1461 1463 O
any 629 632 1464 1467 O
other 633 638 1468 1473 O
metal 639 644 1474 1479 B-treatment
implants 645 653 1480 1488 I-treatment

Male 0 4 1489 1493 B-gender

Meet 0 4 1494 1498 O
DSM-5 5 10 1499 1504 O
criteria 11 19 1505 1513 O
for 20 23 1514 1517 O
current 24 31 1518 1525 O
( 32 33 1526 1527 O
i.e. 33 37 1527 1531 O
, 37 38 1531 1532 O
last 39 43 1533 1537 O
month 44 49 1538 1543 O
) 49 50 1543 1544 O
PTSD 51 55 1545 1549 B-chronic_disease

Meet 0 4 1550 1554 O
criteria 5 13 1555 1563 O
for 14 17 1564 1567 O
current 18 25 1568 1575 O
( 26 27 1576 1577 O
i.e. 27 31 1577 1581 O
, 31 32 1581 1582 O
last 33 37 1583 1587 B-upper_bound
6 38 39 1588 1589 I-upper_bound
months 40 46 1590 1596 I-upper_bound
) 46 47 1596 1597 O
Substance 48 57 1598 1607 O
Use 58 61 1608 1611 O
Disorder 62 70 1612 1620 O
( 71 72 1621 1622 O
SUD 72 75 1622 1625 O
) 75 76 1625 1626 O
using 77 82 1627 1632 O
a 83 84 1633 1634 O
modified 85 93 1635 1643 O
version 94 101 1644 1651 O
of 102 104 1652 1654 O
the 105 108 1655 1658 O
MINI 109 113 1659 1663 O
7.0 114 117 1664 1667 O
( 118 119 1668 1669 O
i.e. 119 123 1669 1673 O
, 123 124 1673 1674 O
must 125 129 1675 1679 O
meet 130 134 1680 1684 O
DSM-5 135 140 1685 1690 O
criteria 141 149 1691 1699 O
for 150 153 1700 1703 O
SUD 154 157 1704 1707 O
in 158 160 1708 1710 O
the 161 164 1711 1714 O
past 165 169 1715 1719 B-upper_bound
6 170 171 1720 1721 I-upper_bound
months 172 178 1722 1728 I-upper_bound
instead 179 186 1729 1736 O
of 187 189 1737 1739 O
12 190 192 1740 1742 O
months 193 199 1743 1749 O
) 199 200 1749 1750 O

Must 0 4 1751 1755 O
consent 5 12 1756 1763 O
to 13 15 1764 1766 O
complete 16 24 1767 1775 O
all 25 28 1776 1779 O
treatment 29 38 1780 1789 B-treatment
and 39 42 1790 1793 O
follow 43 49 1794 1800 O
- 49 50 1800 1801 O
up 50 52 1801 1803 O
visits 53 59 1804 1810 O

Must 0 4 1811 1815 O
consent 5 12 1816 1823 O
to 13 15 1824 1826 O
random 16 22 1827 1833 O
assignment 23 33 1834 1844 O
to 34 36 1845 1847 O
doxazosin 37 46 1848 1857 B-treatment
or 47 49 1858 1860 O
placebo 50 57 1861 1868 B-treatment

Previous 0 8 1869 1877 B-treatment
treatment 9 18 1878 1887 I-treatment
with 19 23 1888 1892 I-treatment
doxazosin 24 33 1893 1902 I-treatment

Subjects 0 8 1903 1911 O
experiencing 9 21 1912 1924 O
significant 22 33 1925 1936 O
withdrawal 34 44 1937 1947 O
symptoms 45 53 1948 1956 O
, 53 54 1956 1957 O
as 55 57 1958 1960 O
evidence 58 66 1961 1969 O
by 67 69 1970 1972 O
a 70 71 1973 1974 O
score 72 77 1975 1980 O
of 78 80 1981 1983 O
10 81 83 1984 1986 B-lower_bound
or 84 86 1987 1989 O
above 87 92 1990 1995 O
on 93 95 1996 1998 O
the 96 99 1999 2002 O
Clinical 100 108 2003 2011 B-clinical_variable
Institute 109 118 2012 2021 I-clinical_variable
Withdrawal 119 129 2022 2032 I-clinical_variable
Assessment 130 140 2033 2043 I-clinical_variable
of 141 143 2044 2046 I-clinical_variable
Alcohol 144 151 2047 2054 I-clinical_variable
( 152 153 2055 2056 I-clinical_variable
CIWA 153 157 2056 2060 I-clinical_variable
) 157 158 2060 2061 I-clinical_variable
. 158 159 2061 2062 O
These 160 165 2063 2068 O
subject 166 173 2069 2076 O
will 174 178 2077 2081 O
be 179 181 2082 2084 O
referred 182 190 2085 2093 O
for 191 194 2094 2097 O
clinical 195 203 2098 2106 O
detoxification 204 218 2107 2121 O
and 219 222 2122 2125 O
may 223 226 2126 2129 O
be 227 229 2130 2132 O
re 230 232 2133 2135 O
- 232 233 2135 2136 O
assessed 233 241 2136 2144 O
for 242 245 2145 2148 O
study 246 251 2149 2154 O
eligibility 252 263 2155 2166 O
after 264 269 2167 2172 O
medically 270 279 2173 2182 O
supervised 280 290 2183 2193 O
detoxification 291 305 2194 2208 O
has 306 309 2209 2212 O
been 310 314 2213 2217 O
completed 315 324 2218 2227 O

Subjects 0 8 2228 2236 O
meeting 9 16 2237 2244 O
DSM-5 17 22 2245 2250 O
criteria 23 31 2251 2259 O
for 32 35 2260 2263 O
current 36 43 2264 2271 O
bipolar 44 51 2272 2279 B-chronic_disease
affective 52 61 2280 2289 I-chronic_disease
disorders 62 71 2290 2299 I-chronic_disease
, 71 72 2299 2300 O
as 73 75 2301 2303 O
the 76 79 2304 2307 O
study 80 85 2308 2313 O
protocol 86 94 2314 2322 O
may 95 98 2323 2326 O
be 99 101 2327 2329 O
therapeutically 102 117 2330 2345 O
insufficient 118 130 2346 2358 O

Subjects 0 8 2359 2367 O
must 9 13 2368 2372 O
be 14 16 2373 2375 O
able 17 21 2376 2380 B-language_fluency
to 22 24 2381 2383 I-language_fluency
comprehend 25 35 2384 2394 I-language_fluency
English 36 43 2395 2402 I-language_fluency

Subjects 0 8 2403 2411 O
on 9 11 2412 2414 O
maintenance 12 23 2415 2426 O
anxiolytic 24 34 2427 2437 B-treatment
, 34 35 2437 2438 O
antidepressant 36 50 2439 2453 B-treatment
, 50 51 2453 2454 O
or 52 54 2455 2457 O
mood 55 59 2458 2462 B-treatment
stabilizing 60 71 2463 2474 I-treatment
medications 72 83 2475 2486 I-treatment
which 84 89 2487 2492 O
have 90 94 2493 2497 O
been 95 99 2498 2502 O
initiated 100 109 2503 2512 O
during 110 116 2513 2519 O
the 117 120 2520 2523 O
past 121 125 2524 2528 B-upper_bound
four 126 130 2529 2533 I-upper_bound
weeks 131 136 2534 2539 I-upper_bound

Subjects 0 8 2540 2548 O
taking 9 15 2549 2555 O
psychotropic 16 28 2556 2568 B-treatment
medications 29 40 2569 2580 I-treatment
will 41 45 2581 2585 O
be 46 48 2586 2588 O
required 49 57 2589 2597 O
to 58 60 2598 2600 O
be 61 63 2601 2603 O
maintained 64 74 2604 2614 O
on 75 77 2615 2617 O
a 78 79 2618 2619 O
stable 80 86 2620 2626 O
dose 87 91 2627 2631 O
for 92 95 2632 2635 O
at 96 98 2636 2638 O
least 99 104 2639 2644 O
four 105 109 2645 2649 B-lower_bound
weeks 110 115 2650 2655 I-lower_bound
before 116 122 2656 2662 I-lower_bound
treatment 123 132 2663 2672 B-treatment
initiation 133 143 2673 2683 O
. 143 144 2683 2684 O
This 145 149 2685 2689 O
is 150 152 2690 2692 O
because 153 160 2693 2700 O
initiation 161 171 2701 2711 O
or 172 174 2712 2714 O
change 175 181 2715 2721 O
of 182 184 2722 2724 O
medications 185 196 2725 2736 O
during 197 203 2737 2743 O
the 204 207 2744 2747 O
course 208 214 2748 2754 O
of 215 217 2755 2757 O
the 218 221 2758 2761 O
trial 222 227 2762 2767 O
may 228 231 2768 2771 O
interfere 232 241 2772 2781 O
with 242 246 2782 2786 O
interpretation 247 261 2787 2801 O
of 262 264 2802 2804 O
results 265 272 2805 2812 O

Subjects 0 8 2813 2821 O
with 9 13 2822 2826 O
a 14 15 2827 2828 O
history 16 23 2829 2836 O
of 24 26 2837 2839 O
adverse 27 34 2840 2847 O
reactions 35 44 2848 2857 O
to 45 47 2858 2860 O
quinazolines 48 60 2861 2873 B-allergy_name
or 61 63 2874 2876 O
other 64 69 2877 2882 O
alpha-1 70 77 2883 2890 B-allergy_name
- 77 78 2890 2891 I-allergy_name
antagonists 78 89 2891 2902 I-allergy_name
( 90 91 2903 2904 O
such 91 95 2904 2908 O
as 96 98 2909 2911 O
allergic 99 107 2912 2920 O
reactions 108 117 2921 2930 O
, 117 118 2930 2931 O
priapism 119 127 2932 2940 B-chronic_disease
, 127 128 2940 2941 O
hepatitis 129 138 2942 2951 B-chronic_disease
, 138 139 2951 2952 O
angioedema 140 150 2953 2963 B-chronic_disease
, 150 151 2963 2964 O
or 152 154 2965 2967 O
intraoperative 155 169 2968 2982 B-chronic_disease
floppy 170 176 2983 2989 I-chronic_disease
iris 177 181 2990 2994 I-chronic_disease
syndrome 182 190 2995 3003 I-chronic_disease
) 190 191 3003 3004 O

Subjects 0 8 3005 3013 O
with 9 13 3014 3018 O
abnormal 14 22 3019 3027 O
liver 23 28 3028 3033 O
function 29 37 3034 3042 O
test 38 42 3043 3047 O
( 43 44 3048 3049 O
LFTs 44 48 3049 3053 O
) 48 49 3053 3054 O
as 50 52 3055 3057 O
evidenced 53 62 3058 3067 O
by 63 65 3068 3070 O
laboratory 66 76 3071 3081 O
findings 77 85 3082 3090 O
of 86 88 3091 3093 O
SGOT 89 93 3094 3098 B-clinical_variable
or 94 96 3099 3101 O
SGPT 97 101 3102 3106 B-clinical_variable
greater 102 109 3107 3114 O
than 110 114 3115 3119 O
two 115 118 3120 3123 B-lower_bound
times 119 124 3124 3129 I-lower_bound
normal 125 131 3130 3136 I-lower_bound

Women 0 5 3137 3142 B-gender
who 6 9 3143 3146 O
are 10 13 3147 3150 B-pregnancy
pregnant 14 22 3151 3159 I-pregnancy
, 22 23 3159 3160 O
nursing 24 31 3161 3168 O
or 32 34 3169 3171 O
not 35 38 3172 3175 O
practicing 39 49 3176 3186 O
an 50 52 3187 3189 O
effective 53 62 3190 3199 O
form 63 67 3200 3204 O
of 68 70 3205 3207 O
birth 71 76 3208 3213 O
control 77 84 3214 3221 O

female 0 6 3222 3228 B-gender

